Role of Incretin, Incretin Analogues and Dipeptidyl Peptidase 4 Inhibitors in the Pathogenesis and Treatment of Diabetes Mellitus

QR Code

Role of Incretin, Incretin Analogues and Dipeptidyl Peptidase 4 Inhibitors in the Pathogenesis and Treatment of Diabetes Mellitus

None

Saved in:

Bibliographic Details
Main Authors:	Papazafiropoulou, Athanasia K., Kardara, Marina S., Pappas, Stavros I.
Format:	Electronic Book Chapter
Language:	English
Published:	IntechOpen 2011
Subjects:	Health Sciences
Online Access:	https://www.intechopen.com/chapters/23137
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Dipeptidyl peptidase-1 inhibitors in bronchiectasis
by: Emma Johnson, et al.
Published: (2025-06-01)

UNEXPECTED ADVERSE REACTIONS OF THE DRUGS OF THE GROUP OF INHIBITORS OF DIPEPTIDYL PEPTIDASE-4
by: T. V. Romanova, et al.
Published: (2018-06-01)

The Potential of some Plant Extracts as Radical Scavengers and Dipeptidyl Peptidase-4 Inhibitors
by: Malik et al.
Published: (2019-03-01)

Incretin-Based Treatment Strategy - GLP-1 Receptor Agonists (GLP-1R) or So-Called Incretin Mimetics
by: Perusicova, Jindra, et al.
Published: (2011)

Abnormal gut microbiota and impaired incretin effect as a cause of type 2 diabetes mellitus
by: T. Y. Demidova, et al.
Published: (2022-03-01)

Monitoring Sarcopenia With Incretin Receptor Activator Treatment
by: Zachary T. Bloomgarden
Published: (2025-06-01)

Cardiovascular Effect of Incretin-Based Therapy in Patients with Type 2 Diabetes Mellitus: Systematic Review and Meta-Analysis.
by: Je-Yon Kim, et al.
Published: (2016-01-01)

Bidirectional Interactions Between the Gut Microbiota and Incretin-Based Therapies
by: Vincenzo Trapanese, et al.
Published: (2025-05-01)

Efficacy and safety of dipeptidyl peptidase-4 inhibitors in type 2 diabetes mellitus patients with moderate to severe renal impairment: a systematic review and meta-analysis.
by: Dongsheng Cheng, et al.
Published: (2014-01-01)

The effects of dipeptidyl peptidase-4 inhibitors on bone fracture among patients with type 2 diabetes mellitus: A network meta-analysis of randomized controlled trials.
by: Jun Yang, et al.
Published: (2017-01-01)

Role of Dipeptidyl Peptidase IV/CD26 in Inflammatory Bowel Disease
by: Detel, Dijana, et al.
Published: (2012)

CARDIOPRODUCTIVE EFFECTS OF EXXENATE AMID AND VILDAGLIPTIN INCRETIN MIMETICS IN DOXYRUBRICINE CARDIOMYOPATHY MODELING
by: A. P. TARASOVА, et al.
Published: (2017-09-01)

Comparative effectiveness of dipeptidyl peptidase-4 (DPP-4) inhibitors and human glucagon-like peptide-1 (GLP-1) analogue as add-on therapies to sulphonylurea among diabetes patients in the Asia-Pacific region: a systematic review.
by: Martin C S Wong, et al.
Published: (2014-01-01)

Multiagonists of the “incretin axis” as a promising tool for managing cardiometabolic risk in visceral obesity
by: M. A. Druzhilov, et al.
Published: (2022-05-01)

Protective Roles of the Incretin Hormones Glucagon-Like Peptide-1 and Glucose-Dependent Insolinotropic Polypeptide Hormones in Neurodegeneration
by: Hölscher, Christian
Published: (2011)

Impact of Incretin Mimetics on Thyroid Cancer Among Patients with Type 2 Diabetes: A Retrospective Cohort Time-to-Event Analysis
by: Michael W. Strand, et al.
Published: (2025-04-01)

Incretin‐Based Therapies in Alzheimer's and Parkinson's Disease: Advancing Neuroprotection With Dual and Triple Agonists—A Review
by: Ousman Mohammed, et al.
Published: (2025-07-01)

Aktivitas Penghambatan Dipeptidyl peptidase-4 (DPP-4) dan Skrining Fitokimia Ekstrak Buah Api-api (Avicennia marina)
by: Dwi Hadi Setya Palupi, et al.
Published: (2025-06-01)

Dipeptidyl peptidase-4 enzyme inhibition and its impacts on hepatic preneoplasia: a new avenue for liver cancer management
by: Hebatollah E. Eitah, et al.
Published: (2025-07-01)

The dipeptidyl peptidase-IV inhibitor gemigliptin alone or in combination with NVP-AUY922 has a cytotoxic activity in thyroid carcinoma cells
by: Si Hyoung Kim, et al.
Published: (2017-10-01)

PANCREATIC AND EXTRA-PANCREATIC EFFECTS OF INCRETINS AND PERSPECTIVES FOR STUDYING ENTEROINSULIN HORMONAL SYSTEM DURING GESTATIONAL DISORDER OF CARBOHYDRATE METABOLISM
by: T. V. Saprina, et al.
Published: (2013-06-01)

Association between use of sodium-glucose cotransporter 2 inhibitors, glucagon-like peptide 1 agonists, and dipeptidyl peptidase 4 inhibitors with kidney outcomes in patients with type 2 diabetes: A systematic review and network meta-analysis.
by: Shuo Yang, et al.
Published: (2022-01-01)

Comparison of New‐Onset Peripheral Artery Disease in Patients With Type 2 Diabetes Exposed to Sodium–Glucose Cotransporter‐2 Inhibitors, Dipeptidyl Peptidase‐4 Inhibitors, or Glucagon‐Like Peptide‐1 Agonists: A Population‐Based Cohort Study
by: Oscar Hou‐In Chou, et al.
Published: (2025-06-01)

Symptomatic Adverse Events and Quality of Life Related to Incretin-Based Medicines for Obesity: A Systematic Review Involving >400,000 Subjects
by: Robert F. Kushner, et al.
Published: (2025-04-01)

Bio-Adrenomedullin and Dipeptidyl Peptidase 3 as Novel Sepsis Biomarkers in the Emergency Department and the Intensive Care Unit: A Narrative Review
by: Ioannis Ventoulis, et al.
Published: (2025-06-01)

Long-term use of dipeptyl peptidase-4 inhibitors suppresses systemic oxidative stress in rats with type 2 diabetes
by: S. S. Bolevich, et al.
Published: (2019-12-01)

Targeting dipeptidyl peptidase-8/9 to combat inflammation-induced osteoclastogenesis in RAW264.7 macrophages and analysis of anti-osteoclastogenesis potential of chrysin
by: Syed Sufian Ahmad, et al.
Published: (2025-04-01)

FEATURES ENZYMATIC RELEASE BIOCOMPATIBLE MICROCAPSULES WITH BUILT-IN SHELL INHIBITOR PEPTIDASE
by: E. V. Popova, et al.
Published: (2019-01-01)

Role of Vitamin D in the Pathogenesis and Therapy of Type 1 Diabetes Mellitus
by: Busta, Agustin, et al.
Published: (2011)

Pathogenesis of anemia in pregnant women with gestational diabetes mellitus
by: A. P. Zima, et al.
Published: (2020-07-01)

Glucokinase: evolution, regulatory properties, role in the pathogenesis of type 2 diabetes mellitus
by: L. A. Kuznetsova, et al.
Published: (2025-07-01)

Role of gut microbiota in the pathogenesis of type 2 diabetes mellitus (literature review)
by: S.M. Koval, et al.
Published: (2021-12-01)

Estimation Activity And Partial Purification Of Leucine Amino Peptidase (Lap) In Patients Wiith Diabetic Nephropathy
by: Baghdad Science Journal
Published: (2012-12-01)

Anoikis-related gene PDK4 and pathogenesis of type 2 diabetes mellitus： A bioinformatics-based study
by: ZHANG Ke, ZHANG Weiyi, SUN Haitian, CAO Mingfeng, ZHANG Xinhuan
Published: (2025-02-01)

The role of morphofunctional complexes and somnological signs of the pathogenesis of gestational diabetes mellitus in overweight women
by: T. L. Botasheva, et al.
Published: (2023-07-01)

The system of tumor necrosis factor α in the pathogenesis of autoimmune diabetes mellitus
by: T. S. Prokhorenko, et al.
Published: (2011-02-01)

The role of the neural NO synthase adapter protein in the pathogenesis of metabolic syndrome and type 2 diabetes mellitus
by: L. A. Kuznetsova, et al.
Published: (2023-10-01)

PATHOGENESIS OF ARTERIAL HYPERTENSION IN DIABETES MELLITUS AND ADVERSE EFFECTS OF HYPOTENSIVE MEDICATIONS USED
by: S. R. Mravyan, et al.
Published: (2001-02-01)

Pathogenesis, treatment, and prevention of arterial hypertension in Type 2 diabetes mellitus patients
by: V. S. Volkov, et al.
Published: (2008-06-01)

HEART FAILURE AND DIABETES MELLITUS: SELECTED ISSUES OF ETIOLOGY AND PATHOGENESIS, PROGNOSIS AND TREATMENT
by: B. U. Mardanov, et al.
Published: (2017-01-01)